Stock in semiconductor-maker Renesas yesterday slipped to its lowest level on record in Tokyo, after the announcement of the company's plans to slash thousands of jobs and raise 100 billion yen (roughly 1.3 billion US dollars).
Renesas, whose semiconductors are used in a number of product ranging from consumer electronics to auto mobiles, announced that it had plans to slash its workforce by 10,000 jobs.
Following the announcement, shares in Renesas shed as much as 16 per cent to 206 yen. It was the lowest level since the company's initial public offering (IPO) in July 2003.
The job cuts are a part of the company's restructuring program, which according to a person familiar with the matter has already been presented to workers' union and lenders Mitsubishi UFJ Financial Group and Mizuho Financial Group.
Renesas, which reported a net loss of 62.6 billion yen for the twelve-month period ended March 31, is 91 percent owned by NEC Corp., Hitachi Ltd. and Mitsubishi Electric Corp.
Analysts expect Renesas to keep on suffering from low margins. Merrill Lynch analysts Simon Dong-je Woo wrote in a report, "We expect Renesas Electronics to continue to suffer from low margins."
The list of Renesas' customers includes Apple, Sony and Nintendo Co.
In a Tuesday announcement, Supergiant Games studio’s founder Greg Kasavin said that the studio -- the creator of games like Bastion and Transistor -- has plans underway to launch a new action-RPG in 2017.
According to the announcement,...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
Electric vehicle manufacturer Tesla has said in a recent...
In an advisory published last Thursday, the US Computer...
In its annual Environmental Responsibility Report for...
Bigwig US wireless carrier AT&T's prepaid service...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).